Stock UniverseDerived research view · source repositories remain read-only

Protalix BioTherapeutics, Inc. (PLX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
22.12
Global Rank
3078
Market Cap
231.61M
Latest Close
1.99
RS Composite
-15.37% · G#2405

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-1.49%
3M
-24.05%
6M
15.70%
1Y
24.37%
3Y
-4.78%
5Y
-34.54%
10Y
-75.12%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 545.87K · 30-day average: 811.79K · Max drawdown over stored range: -94.38%

Research Snapshot

Relative Strength vs SPX

RS Composite-15.37%
20D RS-0.13%
60D RS-40.11%
120D RS1.75%
Global RS Rank2405 · 28.32% percentile
Watch+Speculative RS Rank1494 · 28.76% percentile
Group ScopeWatch+Speculative
Primary RS Rank251 · 45.20% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank374 / 701
Primary Percentile46.79
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for PLX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue62.89838.3547.63865.49453.39952.744
Revenue Growth (YoY)15.002%-39.028%24.219%37.483%-18.467%-1.227%
Gross Profit52.02522.00128.04642.51229.08
Operating Income2.71-20.462-13.01410.463.917
Free Cash Flow-26.761-11.744-25.628-2.4677.392-13.631
Free Cash Flow Per Share-0.918-0.266-0.529-0.030.091-0.173541
EPS (Diluted) GAAP-0.223788-0.624872-0.3099990.0866730.036653
EPS Growth9600%9600%9600%9600%-57.711%
EPS Non-GAAP
Gross Margin82.713%57.369%58.873%64.91%54.458%48.8226%
Operating Margin4.309%-53.356%-27.319%15.971%7.335%-10.4277%
Profit Margin-10.371%-71.922%-31.334%12.691%5.491%-12.5209%
Free Cash Flow Margin-42.547%-30.623%-53.797%-3.767%13.843%-25.8437%
Shares Outstanding (Diluted)29.14844.140248.472282.42481.057278.5462
Shares Change (YoY)96.439%51.435%9.814%70.044%-1.658%-3.098%

SEC Quarterly Fundamentals

No processed quarterly rows for PLX.